<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-title>Mediators of Inflammation</journal-title><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18475596</article-id><article-id pub-id-type="pmc">2365589</article-id>
		<article-id pub-id-type="pii">S0962935194000657</article-id>
		<article-id pub-id-type="doi">10.1155/S0962935194000657</article-id>
	<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Inhibition of Immune Complex-Induced Inflammation by A small Molecular Weight Selectin Antagonist</article-title></title-group><contrib-group>
		<contrib contrib-type="author"><name><surname>Nair</surname><given-names>X.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
		<contrib contrib-type="author"><name><surname>Todderud</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
		<contrib contrib-type="author"><name><surname>Davern</surname><given-names>L.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
		<contrib contrib-type="author"><name><surname>Lee</surname><given-names>D.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
		<contrib contrib-type="author"><name><surname>Aruffo</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib>
		<contrib contrib-type="author" corresp="yes"><name><surname>Tramposch</surname><given-names>K. M.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
	</contrib-group>
		<aff id="aff1"><label>1</label>
			<addr-line>3005 First Avenue</addr-line>
			<addr-line>Seattle</addr-line>
			<addr-line>WA</addr-line>
			<addr-line>98121</addr-line>
			<country>USA</country>
		</aff>
		<aff id="aff2"><label>2</label>
			<addr-line>Bristol-Myers Squibb Pharmaceutical Research Institute</addr-line>
			<addr-line>100 Forest Avenue</addr-line>
			<addr-line>Buffalo</addr-line>
			<addr-line>NY</addr-line>
			<addr-line>14213</addr-line>
			<country>USA</country>
		</aff>
	<pub-date pub-type="ppub"><year>1994</year></pub-date><volume>3</volume><issue>6</issue><fpage>459</fpage><lpage>463</lpage><permissions><copyright-statement>Copyright &#x000a9; 1994 Hindawi Publishing Corporation.</copyright-statement><copyright-year>1994</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
		<p>The anti-inflammatory effect of a small molecular weight antagonist
of P- and E-selectin-dependent cell adhesion was examined. The
glycolipid sulphatide was shown to block the adherence of
thrombin-activated rat platelets to HL-60 cells. This interaction is
known to be dependent on P-selectin. The rat dermal reverse passive
Arthus reaction was used to assess the effect of sulphatide on a
neutrophil dependent inflammatory response. Sulphatide
dosedependently blocked both the vascular permeability increase and
cell infiltration after intraperitoneal administration. These
results show that a small molecular weight compound which blocks P-
and E-selectin dependent adhesion <italic>in vitro</italic> can
effectively block the inflammation due to immune complex deposition.
A compound with this type of profile may have therapeutic potential
in the treatment of immune complex mediated diseases.</p>
	</abstract></article-meta></front></article>


